REASONS FOR AUTOMATION IN BLOOD SERVICE
NATIONAL BLOOD STANDARDS, EGYPT EXPERIENCE
QUALITY ASSURANCE IN AFRICA
TRANSFUSION IN TUNISIA
CHAGAS AND OTHER PROTOZOAN DISEASES
THE GLOBALIZATION OF CHAGAS DISEASE
DIAGNOSTIC EVALUATION OF FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAITP)
SET UP OF TRIALS, REPORTING AND PUBLISHING
DO WE REALLY KNOW THE REAL RISKS OF APHERESIS DONATION?
THE ECONOMICS OF BLOOD TRANSFUSION IN THE XXI CENTURY
NEW DEVELOPMENTS IN THE BIOLOGICAL ACTIVITY OF MONOCLONAL ANTIBODIES
PREVENTING THE IMMUNE RESPONSE TO RHD BY PEPTIDE TOLERISATION
FATAL HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY ANTI-JRA ANTIBODY
FAETUS FATAL HAEMOLYTIC DISEASE BY ANTI-JKB, A CASE REPORT
INFLUENCE OF THE EPIDEMIOLOGICAL FACTORS ON BLOOD TRANSFUSION
PRECISE MATCH
THE RISK OF HIV TRANSMISSION BY TRANSFUSION IN ITALY DOES NOT INCREASE AFTER THE ABOLITION OF BAN ON BLOOD DONATIONS FROM HOMOSEXUAL MEN
DETECTION OF CHAGAS DISEASE ANTIBODIES IN BLOOD DONORS BY TIA (TRANS-SIALIDASE INHIBITION ASSAY)
SIMULATION MODELING OF TRANSFUSION-TRANSMITTED MALARIA RISK IN THE USA
CORD BLOOD BANKING AND ACCREDITATION
INTRODUCTION OF CD34+ CELL CONTENT AS CRITERIA FOR UMBILICAL CORD BLOOD CRYOPRESERVATION
UMBILICAL CORD BLOOD TRANSPLANTS IN ADULTS WITH CO-TRANSPLANTATION OF CD34+ CELLS FROM A SECOND DONOR
PROFILE OF STORED AND TRANSPLANTED CORD BLOOD UNITS FROM SPANISH CORD BLOOD BANK
ADSORPTIVE MONOCYTE AND GRANULOCYTE APHERESIS IN THE CHRONIC INFLAMMATORY ILLNESS
IMMUNOLOGIC MARKERS OF EFFICACY IN PATIENTS UNDERGOING EXTRACORPOREAL PHOTO CHEMOTHERAPY
THE USE OF A SIMPLIFIED ADSORPTION SYSTEM FOR ABO-INCOMPATIBLE KIDNEY TRANSPLANTS
AUTOLOGOUS DONATIONS WITH THE ALYX COMPONENT COLLECTION SYSTEM ASSOCIATED WITH INTRAVENOUS IRON TREATMENT
EFFICACY OF A NURSING EDUCATIONAL PROGRAM ON APHERESIS DONATION PERFORMANCE
WHAT IS THE EVIDENCE FOR CLINICAL EFFECTIVENESS OF BLOOD TRANSFUSION?
LOW IMMUNIZATION RATE IN SICKLE CELLS PEDIATRIC PATIENTS
AN EFFECTIVE TRANSFUSION STRATEGY FOR LIMITING THE DONOR EXPOSURE IN NEWBORNS AND INFANTS BY USING PAEDIATRIC MINI-BAGS
EVALUATION OF D+ RBCS TRANSFUSION TO D- PATIENTS
THE EFFECT OF PROTOCOLLED BLOOD TRANSFUSIONS IN RECIPIENTS OF A SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT
THE ROLE OF THE LOW FREQUENCY ANTIGENS IN NAIT
SCREENING OF ANTI-HPA-1A IN HPA-1A NEGATIVE MOTHERS
A NEW IN VITRO ASSAY DETECTING HPA-1A-SPECIFIC ANTIBODIES BASED ON PEPTIDE APTAMER TECHNOLOGY
A NEW POLYMORPHISM IN THE PLATELET GLYCOPROTEIN GPIIIA, MAT(A), ASSOCIATED WITH SEVERE NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
HNA-1A, HNA-1B, AND HNA-1C (NA1, NA2 AND SH) FREQUENCIES IN ARGENTINEAN POPULATION
PRODUCTION OF THE FIRST HUMAN MONOCLONAL ANTIBODY HIGHLY SPECIFIC FOR HPA-5B ALLOANTIGEN. APPLICATION FOR THE PHENOTYPING OF PLATELETS
CLUB 25
CHARACTERISTICS OF VOLUNTARY NON-REMUNERATED BLOOD DONORS IN PAKISTAN
PSYCHO-SOCIAL AND PHYSICAL EFFECTS OF BLOOD DONATION
OPTIMAL POLICY FOR USE OF PLATELET CONCENTRATES IN GREECE
THE NEW DEAL OF THE ITALIAN BLOOD SYSTEM
INTERACTION BETWEEN THE BAND 3 PROTEIN AND RH COMPLEX IN SENESCENT ERYTHROCYTES
INFECTIVITY OF ANTI-HBC REACTIVE BLOOD PRODUCTS - CASE CONTROL STUDY
THE CONTRIBUTION OF DR. DURAN-JORDA TO THE ADVANCE AND DEVELOPMENT OF THE EUROPEAN BLOOD TRANSFUSION
WARM STORAGE OF WHOLE BLOOD FOR 72 HOURS
DESIGN OF A MODERN BLOOD COMPONENT MANUFACTURING FACILITY
HISTORY OF BLOOD TRANSFUSION IN THE REPUBLIC OF SERBIA
THE DIFFERENT TOOLS IN THE QUALITY MANAGEMENT
THE SPANISH BLOOD TRANSFUSION ACCREDITATION COMMITTEE EXPERIENCE
FROM IN HOUSE MINI-POOL NAT TO CE ACCREDITED IVD IMPROVEMENT IN BLOOD SAFETY
MONITORING AND IMPROVEMENT OF DOCUMENTATION REQUIREMENTS FOR BLOOD DELIVERING AND TRANSFUSION PROCESS
MICROARRAY TECHNOLOGY AND ITS APPLICATION TO BLOOD GROUPING
MOLECULAR GENETIC INVESTIGATION OF BLOOD DONORS WITH WEAK RHE EXPRESSION REVEALS A BROAD SPECTRUM OF DIVERSE POLYMORPHISMS
MASS SCREENING FOR RHD GENE FRAGMENTS IN RHD NEGATIVE DONORS BY MINIPOOL TESTING SYSTEM USING REAL TIME PCR TECHNOLOGY
WEAK BLOOD GROUP B PHENOTYPES CAUSED BY VARIATIONS IN THE CBF-NFY ENHANCER REGION OF THE ABO GENE
TREATMENT OF MASSIVELY BLEEDING PATIENTS - TIME TO CHANGE?
MASSIVE BLOOD TRANSFUSION AND COAGULOPATHY
EFFECT OF PLATELET ACTIVATION ON BLEEDING AND TRANSFUSION RATES IN PATIENTS UNDERGOING HIGH RISK CARDIAC SURGERY
EVALUATION OF FRESH FROZEN PLASMA TRANSFUSION PRACTICES IN KOREAN HOSPITAL
CONTINUING EDUCATION IN TRANSFUSION MEDICINE
RAPID ALERT
HEMOVIGILANCE FOR TRANSFUSION OF INTERCEPTTM PLATELETS IN ROUTINE THERAPEUTIC USE
PREVENTION OF IMMUNE TRALI BY SCREENING FOR LEUKOCYTE ANTIBODIES
RISK OF HBV-DNA-POSITIVE, HBSAG -NEGATIVE DONATIONS REDUCED BY ANTI-HBC TESTING
5 YEARS BACTERIAL SCREENING OF PC IN THE NETHERLANDS
IMPACT OF INDIVIDUAL DONATION (ID)-NAT ON THE RISK OF TRANSFUSION TRANSMITTED HIV INFECTIONS IN SOUTH AFRICA
THE STRENGTHS AND WEAKNESSES OF THE EVIDENCE BASE FOR IMPROVING TRANSFUSION PRACTICE
DETECTION OF MICROCHIMERISM IN NORMAL BLOOD DONORS
RED CELL TRANSFUSION FOR IRON DEFICIENCY ANAEMIA
ASSOCIATION OF ANTI-LEUKOCYTE ANTIBODIES WITH TRALI PARTLY EXPLAINED BY PUBLICATION BIAS
QUALITY OF PLATELET CONCENTRATES FROM POOLED BUFFY-COATS MADE OF FRESH WHOLE BLOOD PROCESSED ON ATREUS 2C+ SYSTEM
ALTERATION OF PLATELET PROTEINS DURING STORAGE ASSESSED BY PROTEOMICS
PLATELETS STORED AT 4°C, AN EVALUATION OF PLATELETS IN SSP+ ADDITIVE SOLUTION
POST AUTHORIZATION SURVEILLANCE OF PLATELET CONCENTRATES AFTER TRANSFUSION
TTP AND PREGNANCY
THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
LACK OF EFFECTIVENESS OF PLASMA-EXCHANGE IN CANCER-RELATED THROMBOTIC THROMBOCYTOPENIC PURPURA
METHYLENE BLUE PHOTOINACTIVATED PLASMA (MBPIP) VS. FRESH FROZEN PLASMA (FFP) IN THE TREATMENT OF IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
RITUXIMAB FOR TREATMENT OF PATIENTS WITH REFRACTORY OR RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA
DATA INTERCHANGE AND RELATED TECHNOLOGIES IN TRANSFUSION MEDICINE
MANAGEMENT OF A HOSPITAL BLOOD BANK USING RADIO-FREQUENCY IDENTIFICATION (RFID)
USING GLOBAL POSITIONING SYSTEMS TO ENHANCE PRODUCTIVITY IN A BLOOD CENTER
FULL UNIT TRACKING ‘FROM VEIN TO VEIN’. THE EXPERIENCE OF THE CENTRAL HOSPITAL IN CIUDAD REAL (SPAIN)
ERRARE HUMANUM EST...BUT IT IS ALSO HUMAN TO PREVENT ERRORS
PROCESS CONTROLS TO AVERT MISTRANSFUSION
HEMOLYTIC TRANSFUSION REACTIONS FOLLOWING ADMINISTRATION OF INTRAVENOUS GAMMAGLOBULIN
ADDITIONAL BENEFITS OF HAEMOVIGILANCE
QUALITY MANAGEMENT IN IMMUNOHEMATOLOGY
PHARMACOLOGICAL MANAGEMENT OF PERIOPERATIVE ANAEMIA
PERIOPERATIVE BLOOD CONSERVATION
DOES PRE-OPERATIVE CORRECTION OF ANAEMIA REDUCE THE NEED OF RED CELL TRANSFUSION IN PATIENTS UNDERGOING MAJOR JOINT SURGERY?
ALLOGENEIC BLOOD TRANSFUSION SAVING PROGRAM BASED ON SELECTED PRE-SURGICAL AUTOLOGOUS BLOOD COLLECTION OR STIMULATION OF ERYTHROPOIESIS FOR PATIENTS UNDERGOING SPINE SURGERY
DISASTER-PREPAREDNESS PLAN AT SAINT-GEORGE UNIVERSITY MEDICAL CENTER DURING THE SUMMER 2006 WAR AND BLOCKADE ON LEBANON
PREVENTION OF GRAFT-VERSUS-HOST DISEASE GVHD BY ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS (AD-MSCS) IN ALLOGENEIC BONE MARROW TRANSPLANTS.
IMPROVEMENT OF MESENCHYMAL CELL EXPANSION AND DIFFERENTIATION IN BONE-FORMING CELLS BY MEANS OF PLATELET-DERIVED FACTORS
EX VIVO MODULATION OF THE ALLOREACTIVITY OF PRIMARY NK CELLS
A PRELIMINARY STUDY ON THE BIOLOGICAL CHARACTERS AND FUNCTION OF EXOSOMES DERIVED FROM DENDRITIC CELLS
PLATELET RICH PLASMA PRP AND PLATELET DERIVATIVE FOR TOPICAL THERAPY. WHAT IS TRUE?
STERILIZATION OF PLATELET CONCENTRATES BY IRRADIATION WITH SHORT-WAVE ULTRAVIOLET LIGHT
NET COST IMPACT OF IMPLEMENTATION OF PHOTOCHEMICAL PATHOGEN INACTIVATION (INTERCEPT BLOOD SYSTEM FOR PLATELETS) FOR PREPARATION OF PLATELET COMPONENTS
SURVEILLANCE STUDY OF THE TRANSFUSION EFFICIENCY AFTER TRANSFUSIONS OF APHERESIS PLATELET CONCENTRATES AND POOLED PLATELET CONCENTRATES
COMPARATIVE STUDY OF FIBRIN SEALANT PREPARED FROM CONVENTIONAL AND INTERCEPT BLOOD SYSTEM PLASMA USING THE CRYOSEAL FS-SYSTEM
ROUTINE CLINICAL PRACTICE OF FETAL RHD GENOTYPING USING MATERNAL PLASMA IN BELGIUM
THE GERMAN FEASIBILITY STUDY ON NON-INVASIVE DETERMINATION OF THE FETAL D-STATUS FROM MATERNAL PLASMA FOR DECISION MAKING ON RH-PROPHYLAXIS
GOVERNMENT, MEDIA AND DECISION MAKING IN TRANSFUSION MEDICINE
THE COMMUNITY ROLE IN ENHANCEMENT OF VOLUNTARY, NON-REMUNERATED BLOOD DONATION IN THE NEW MILLENNIUM
POSITIVE IMPACT OF BLOOD DONORS TESTING IN A COUNTRY WITH LIMITED RESOURCES
MULTILEVEL DECISION OF THE SPECIALISTS IN TRANSFUSION MEDICINE IN THE SYSTEM OF BLOOD SAFETY IN A COUNTRY WITH LIMITED RESOURCES
BANC DE SANG I TEIXITS
PROPOSAL OF NATIONAL BLOOD POLICY IN REPUBLIC OF MACEDONIA
IMPACT OF THE UK FREEDOM OF INFORMATION ACT ON THE SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE (SNBTS)
REORGANISATION AND EFFECTUAL LEADING IN NATIONAL BLOOD TRANSFUSION MEDICINE IN SERBIA
REQUIRED METHODS AND ASPECTS OF TRANSFUSIOLOGY IN THE PROCEDURE OF LIVER TRANSPLANTATION
ANNUAL BLOOD NEED OF TURKEY
SOFTWARE TOOLS IMPROVING THE CONTINUITY OF MEDICAL SUPERVISION FOR CLINICAL HAEMATOLOGY RELATED HOME CARE
EVOLUTION OF RUSSIAN BLOOD SERVICE
VOLUNTARY, NON-RENUMERATED BLOOD DONATION
VOLUNTARY BLOOD DONORS OF TURKISH RED CRESCENT BLOOD CENTERS
THE EFFICACY OF ESTABLISHING A DONOR HAEMOGLOBIN CLINIC IN THE KUWAIT CENTRAL BLOOD BANK
DEFERRAL RATE DUE TO ANEMIA IN BRAZILIAN BLOOD DONORS
NEW APPROACHES IN BLOOD DONOR MOTIVATION ACTIVITIES
ROUTINE AND EMERGENCY EXTERNAL PUBLIC RELATIONS ACTIVITIES OF THE BLOOD TRANSFUSION INSTITUTE OF SERBIA TWO YEARS SURVEY
STATISTIC PROFILE OF DONATIONS IN EXTREMADURA IN 2006
SOCIO-DEMOGRAPHIC CHARACTERISTIC OF BLOOD DONORS IN NATIONAL INSTITUTE FOR TRANSFUSION MEDICINE IN SKOPJE - REPUBLIC OF MACEDONIA IN 2006 YEAR
IRON DEFICIENCY IN FREQUENT AND FIRST TIME FEMALE BLOOD DONORS
A NEW EDUCATION PROPOSAL
COMPARISON OF RETURN RATES OF TEMPORARILY DEFERRED DONORS WITH THOSE OF UNDEFERRED DONORS
RARE BLOOD DONOR PROGRAMME IN GREECE
BLOOD UTILIZATION MANAGEMENT AND ACUTE HEART FAILURE IN A CHILD
EXPERIENCES OF ALYX COMPONENT COLLECTION SYSTEM IN A MOBILE ENVIRONMENT
THE EVALUATION OF BLOOD DONOR DEFERRAL CAUSES
IMPROVING VNRBD RATES IN THE AMERICAS THROUGH THE IMPLEMENTATION OF THE CLUB 25 METHODOLOGY
DONORS RECRUITMENT
THE IMPACT OF A DECREASE IN THE DONOR DEFERRAL PERIOD FOR TRANSMISSIBLE DISEASE RISK FACTORS FROM 12 MONTHS TO 6 MONTHS
EDUCATING - AND PERSUADING - THE NEXT GENERATION OF BLOOD DONORS
BLOOD DONATION IN A TIME-STARVED CULTURE
BLOOD DONATION AMONG HIGH SCHOOL STUDENTS IN REPUBLIC OF MACEDONIA 5 YEAR SURVEY
MOBILE BLOOD DONATION CAMPAIGN FOR VOCATION AREAS
HIV TESTING AS THE MOTIVATION FACTOR FOR BLOOD DONATION IN IRANIAN BLOOD DONORS
LOW FERRITIN LEVELS MAY PLAY A PROTECTIVE ROLE AGAINST ACUTE ISCHEMIC CARDIOPATHY IN BLOOD DONORS
THE SELECTION OF DONORS
THE IMPACT OF POPULATION CHANGES ON BLOOD DONATIONS, A COMPARATIVE ANALYSIS OF THE DECADE 1996-2006
INFLUENCE OF THE SEX AND FREQUENCY OF THE DONATION IN THE METABOLISM OF THE DONORS
BLOOD DONORS DEFERRAL
CONTROL OF THE HEALTH CONDITION OF BLOOD DONORS WITH THE PRESENCE OF MARKERS OF HEPATITIS B AND C
BLOOD DONATION ORGANISATION BY MEDICAL STUDENTS FOR PEDIATRIC PATIENTS
BLOOD DONORS WITH TRANSFUSION HISTORY
EFFECT OF SHORT-TERM FERROUS SULFATE ON IRON STORES IN FEMALE BLOOD DONORS
FROM IDEA TO TRADICIONAL BLOOD DONOR SESSION
LOW KNOWLEDGE'S LEVEL OF BLOOD DONORS IN BURKINA FASO (WEST AFRICA); A POTENTIAL RISK FOR BLOOD AND TRANSFUSION SAFETY
REACTIONS OF VOLUNTARY BLOOD DONORS
DONOR HAEMOVIGILANCE IN JAPAN
PROFILE OF THE DONOR OF BONY MARROW IN THE CTS-HUELVA IN 2007
PROFILE OF THE DONOR OF PLAQUETOFRESIS IN THE CTS-HUELVA IN 2007
ETHICAL AND PSYCHOLOGICAL IMPLICATIONS OF A CHILDRENS COMPETITION IN RECRUITING VOLUNTARY BLOOD DONORS
EVALUATION OF CHILDRENS COMPETITION AS A COMMUNICATION TOOL IN PROMOTING VOLUNTARY BLOOD DONATION
STUDY ON DEMOGRAPHIC CHARACTERISTICS OF BLOOD DONORS WHO WERE DEFERRED FOR LOW HAEMOGLOBIN
ANALYSIS OF BLOOD DONORS DEFERRAL IN BLOOD TRANSFUSION SERVICES UNITED ARAB EMIRATES EXPERIENCE
THE STUDY OF USEFULNESS OF BARCODE FOR DRAWING REJECTED BLOOD DONORS CONFIDENCE IN RESPECTING TO QUESTIONS WITH A SPECIAL FOCUS ON HIV
PROMOTION OF VOLUNTARY, ANONYMOUS, NONREMUNERATED AND REGULAR BLOOD DONOATION IN BELGRADE STUDENTS POPULATION FROM 2001 TO 2006
EVALUATION OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION IN ELDERLY PATIENTS IN A BLOOD BANK IN ARGENTINA
INCREASE OF DONATIONS AFTER THE APPLICATION OF THE REAL DECRETO 1088/2005 IN SPAIN
IRON STATUS IN BLOOD DONORS
INCIDENCE AND PREVENTION OF VASOVAGAL SYNDROMES IN BLOOD DONORS
THE CHOICE OF BECOMING A BLOOD DONOR
THE CONTRIBUTION OF AVIS (ITALIAN VOLUNTEER BLOOD DONORS ASSOCIATION) REGIONALE LOMBARDIA TO SELF-SUFFICIENCY OF BLOOD AND HEMOCOMPONENTS
INCONSISTENCY IN THE RESPONSES OF REGULAR DONORS TO HEALTH HISTORY QUESTIONS
DISRIBUTION OF THE BLOOD GROUPS O, A, B, AB AND D IN BLOOD GROUP SYSTEMS ABO AND RH WITH POPULATION IN KUMANOVO REGION
WOMEN-BLOOD DONORS IN THE MUNICIPALITY OF KUMANOVO
TRACKING OF HEMOGLOBIN AND FERITINE LEVEL IN VOLUNTARY BLOOD DONORS IN BLOOD TRANSFUSION INSTITUTE NIS
ASSESSMENT OF A SELF-DEFERRAL SCREENING FORM AMONG BLOOD DONORS AT CHIANG MAI UNIVERSITY HOSPITAL, THAILAND
VISTA INFORMATION SYSTEM
PRE-DONATION INTERVIEW
THE CAUSES OF INCOMPLETE BLOOD DONATIONS
LOSSES OF THE SUPPLY OF DONATED BLOOD DUE TO DONOR DEFERRAL, MISCOLLECTION AND LAPSED DONORS
FOLLOWING THE HEALTH CONDICION OF VOLUNTARY REPEATED BLOOD DONORS IN WU TRANSFUSIOLOGY GENERAL HOSPITAL IN STIP
COMPARATIVE STUDY OF HAEMOGLOBIN LEVELS IN PREDONATION TESTING
THE STRATEGY FOLLOWED TO GET A REGISTRY OF ABSOLUTE IGA DEFICIENT BLOOD DONORS IN A COMMUNITY BLOOD CENTRE
AMERINDIAN HLA ALLELES AND BLOOD TRANSFUSIONS
DOUBLE RED CELL COLLECTION USING ALYX; SINGLE CENTER EXPERIENCE
MGUS AND BLOD DONATION
BLOOD GROUP PHENOTYPE PREDICTION BY MULTIPLEX PCR AND POOLED CAPILLARY ELECTROPHORESIS
MNC PROCEDURES FOR DLI IN UNRELATED BLOODBANK DONORS
VISTA INFORMATION SYSTEM CONTRIBUTES TO LEAN MANUFACTURING
RECRUITMENT PROGRAM FOR RED BLOOD CELL APHAERESIS DONORS
IRON METABOLISM IN TWO RED CELL UNIT DONORS
EVALUATION OF THE ALYX SYSTEM FOR THE COLLECTION OF ONE UNIT OF LEUKOREDUCED RBCS AND A CONCURRENT PLASMA PRODUCT
COMPONENT COLLECTION BY DONATION APHERESIS PORTO REGIONAL BLOOD CENTRE (CRSP)
DOUBLE RED BLOOD CELL CONCENTRATE APHERESIS (DRBC) AND CONCURRENT PLATELET-RBC APHERESIS (P-RBC)
INADEQUATE VENOUS APPROACH THE MOST FREQUENT REASON OF THE DEFERRAL OF DONORS IN THE PROGRAM OF PLATELET APHERESIS AT THE BLOOD TRANSFUSION INSTITUTE OF SERBIA
PREAMTURE TERMINATIONS OF PLATELET APHERESIS PROCUDURES IN TWO DIFFERENT APHERESIS SYSTEMS
COMPARISON OF APHERESIS PLATELETS REDUCED USING AUTOMATED BLOOD CELL SEPARATORS
GRANULOCYTE COLLECTIONS WITHOUT SEDIMENTING AGENTS FOR PATIENTS WITH SEVERE FEBRILE NEUTROPENIA
PH EVALUATION HAS A POOR USEFULNESS AS QUALITY CONTROL FOR PLATELET-APHERESIS
COLLECTION OF PERIPHERAL BLOOD PROGENITOR CELLS (PBPC) WITH LARGE VOLUME LEUKAPHERESIS (LVL) IN 65 HEALTHY DONORS FOR HEMATOPOIETIC ALLOGENEIC TRANSPLANTATION
COMPARATIVE STUDY OF TWO DOUBLE RED CELL COLLECTION SYSTEMS
FERRITIN LEVEL, AS A CRITICAL MARKER OF DONOR SUITABILITY AND SAFETY, IN THREE 2-RBCA DONORS POPULATIONS
HIGH T-CELL ACTIVATION IN DONORS PERIPHERAL BLOOD LEADS TO ELEVATED LEUKOCYTE CONTAMINATION IN THEIR APHERESIS PLATELET CONCENTRATES
COMPARISON OF AMICUS AND MCS+ FOR DOUBLE DOSE PLATELET COLLECTIONS
HOW IMPORTANT IS THE AC
ADVERSE REACTIONS IN APHERESIS DONORS
THE USE OF AMICUS SEPARATOR IN A NON-STANDARD PROTOCOL
PLASMAPHERESIS IN ACUTE HUMORAL REJECTION AFTER KIDNEY TRANSPLANTATION
ERYTHROCYTAPHERESIS VERSUS THERAPEUTIC PHLEBOTOMY FOR THE TREATMENT OF THE HEREDITARY HAEMOCHROMATOSIS
THERAPEUTIC ERYTHROCYTAPHERESIS - RESULTS OF 10 YEARS EXPERIENCE WITH HAEMONETICS
THERAPEUTIC LEUKOCYTAPHERESIS AND THROMBOCYTA-PHERESIS WITH HAEMONETICS MCS+
CELL COLLECTION FOR EXTRACORPOREAL PHOTOCHE-MOTHERAPY USING THREE DIFFFERENT CELL SEPARATORS
MMUNOADSORPTION AND PLASMAPHERESIS SHOW POSITIVE EFFECT AFTER KIDNEY TRANSPLANTATION
KINETICS OF IRON MOBILIZATION IN THE TREATMENT OF HEREDITARY HEMOCHROMATOSIS (HH)
SAFETY AND EFFECTIVENESS OF LEUKAPHERESIS IN PATIENTS WITH ACUTE HYPERLEUKOCYTIC LEUKAEMIA
THERAPEUTIC PLASMA EXCHANGE IN THE PATIENT SUFFERING FROM MYASTHENIA GRAVIS
ERYTHROCITAPHERESIS IN HEREDITARY HEMOCHROMATOSIS OF RECENT DIAGNOSIS
MONOCYTE APHERESIS WITH 225 ML LATHAM BOWL (MCS)
TREATMENT OF MYASTHENIA GRAVIS WITH PROTEIN-A MMUNOADSORPTION
MANAGING OF PLASMA TREATMENT IN PATIENTS WITH RELAPSED FORM OF TTP
TTP THERAPY IN A BLOOD BANK SETTING
THROMBOTIC THROMBOCYTOPAENIC PURPURA. CASE REPORT OF A PATIENT ON LONG-TERM THERAPY
BENEFICIAL EFFECTS OF EARLY ADJUNCTIVE TREATMENT USING RITUXIMAB DURING ACUTE REFRACTORY TTP
EVALUATION OF COMPUTERIZED ON-LINE DONOR PROCESSING SYSTEM ON ERROR, DEFERRAL RATE AND DONOR SATISFACTION IN ESFAHAN, 2005
IMPROVEMENT OF HB-CONTENT BY A NEW FILTER FOR RBC LEUKOREDUCTION
QUALITY CONTROL ON BLOOD COMPONENTS PREPARATION LAB IN CENTRAL BLOOD BANK IN KUWAIT DURING 2005
ETHICS IN TRANSFUSION MEDICINE
POOLED PLATELET CONCENTRATES OBTAINED WITH AUTOMATED METHOD
COMPARISON OF IN VITRO PARAMETERS FROZEN RBCS, LEUKO AND NON-LEUKODEPLETED, COLLECTED BY APHERESIS OR FROM WHOLE BLOOD, STORED FOR 21 DAYS AFTER DEGLYCEROLIZATION AND RESUSPENSION IN AS-3 (NUTRICEL).
STATISTICAL PROCESS CONTROL OF THE HEMOGLOBIN CONTENT OF BUFFY-COAT REMOVED, LEUKODEPLETED RED CELL CONCENTRATES
EVALUATION OF BLOOD COMPONENTS COLLECTED BY ABC SYSTEM
BLOOD COMPONENT PREPARATION WITH THE ATREUS 2C+ SYSTEM IN ROUTINE USE
PLATELET CONCENTRATES IN PH READING CONTAINERS
DESIGN OF A NEW LINER IN IRANIAN BLOOD TRANSFUSION ORGANISATION(IBTO) TO PREVENT FOLDING OF BLOOD BAGS WHILE CENTRIFUGING
ERGONOMICS OF A NEW AUTOMATED CENTRIFUGATION/SEPARATION METHOD COMPARED TO A CONVENTIONAL BOTTOM-AND-TOP SYSTEM
USE OF ADDITIVE SOLUTION FOR 10 DAY STORAGE OF PLATELET CONCENTRATES
PLATELET CONCENTRATES OBTAINED IN A BLOOD CENTRE
DEVELOPMENT OF A LEUKO-REDUCING BOWL FOR AN INTERMITTENT PLATELETPHERESIS
VALIDATION OF THE NEW TERUMO ADVANCED COMPONENT CENTRIFUGE WITH SEPARATOR INTEGRATED OF PLATELETS CONCENTRATES FROM BC
INITIAL INTRACELLULAR PH DETERMINES MAINTENANCE OF 2,3-DPG DURING STORAGE OF RED CELL CONCENTRATES
STORAGE-DEPENDENT REMODELING OF THE RBC MEMBRANE IS ASSOCIATED WITH INCREASED IGG BINDING, LIPID RAFT REARRANGEMENT AND CASPASE ACTIVATION
EVALUATION OF LEUKODEPLETED PLATELET CONCENTRATES AFTER 10 DAY STORAGE IN ADDITIVE SOLUTION (SSP+, MACOPHARMA)
PLATELET COUNT FROM PLATELET CONCENTRATES AT DIFFERENT DILUTIONS IS THERE A DIFFERENCE?
EFFECT OF THE INTRODUCTION OF A NEW EXPANDER IN THE IN-LINE FILTER FOR RED CELL CONCENTRATES
QUALITY CONTROL IN RED CELL CONCENTRATES AFTER LEAVING A ‘DRY’ BUFFY-COAT
BLOOD STORED
QUALITY CONTROL OF PLATELET CONCENTRATES - OUR EXPERIENCES
AUTOMATIC PLATELET PROCESSING (ORBISAC) PORTO REGIONAL BLOOD CENTRE
IMPROVED PRODUCTION PROCESS MANAGEMENT (ATREUS/ORBISAC) PORTO REGIONAL BLOOD CENTRE (CRSP)
AUTOMATIC WHOLE BLOOD PROCESSING (ATREUS) PORTO REGIONAL BLOOD CENTRE
COMPARISON OF PLATELET CONCENTRATES STORED IN PLASMA OR IN 3 DIFFERENT ADDITIVE SOLUTIONS
STORAGE OF LEUKOREDUCED RED CELL CONCENTRATES IN PLASTIC OVERWRAPS
COMPARATIVE ANALYSIS OF PLATELET UNITS PREPARED IN 2005 AND 2006
QUALITY ANALYSIS ON FRACTIONATED PLATELET CONCENTRATES STORED FOR 5 DAYS IN A HALVED VOLUME OF PLASMA
THE VOLUME OF STORED PLATELET CONCENTRATES CAN BE REDUCED IN A MANNER WHICH MAINTAINS PLATELET PROPERTIES
IMMATURE PLATELET FRACTION (IPF) AND ITS VALUE TO DETERMINE THROMBOPOIESIS STATUS PRELIMINARY DATA
NEW AUTOMATED APHERESIS SYSTEM FOR LEUKOREDUCED DOUBLE-DOSE RED CELL COLLECTION WITH ADVANTAGES OF REDUCED EXTRACORPOREAL VOLUME AND TRUE MOBILITY
COMPARISON OF BLOOD COMPONENT PREPARATION METHOD OF WHOLE BLOOD BAGS BASED ON BUFFY COAT EXTRACTION
EVALUATION OF LEUKOCYTES SUBPOPULATION IN WHOLE BLOOD BEFORE AND AFTER PRESTORAGE FILTRATION
MINIMAL RESIDUAL DISEASE IN THE APHERESIS PRODUCTS FROM PATIENTS WITH MULTIPLE MYELOMA
L-CARNITINE REDUCES GLYCOLYSIS AND MAINTAINS PH TO DAY 7 IN HYPERCONCENTRATED PLATELET POOLS
ORBISAC BC SYSTEM
PERFORMANCES OF AN UPDATED SOFT-SHELL FILTER FOR LEUKOREDUCTION OF RED CELL CONCENTRATES
IMPLEMENTATION OF THE AUTOMATED ORBISAC BC SYSTEM TO PREPARE WHOLE BLOOD DERIVED PLATELET CONCENTRATES AT THE EFS ALPES MEDITERRANEE BLOOD CENTER
CRYOPRESERVED VS. LIQUID STORED PLATELETS - FROM THE BASIC TO THE UP TO DATE FINDINGS
RED BLOOD CELLS
HUMAN PLASMA FRACTIONATION PROGRAM
AN ECONOMICAL PROCESS FOR PRODUCTION OF HUMAN SERUM ALBUMIN 20%
WHY SHOULD TURKEY HAVE A PLASMAFRACTIONATION INDUSTRY?
STUDY ABOUT THE CAUSES OF DESTRUCTION OF PLASMA
LOOK BACK STUDY ON IRANIAN SEROCONVERTED DONORS THAT THEIR PLASMA SENT FOR FRACTIONATION
THE PREVALENCE OF HTLV I-II IN BLOOD DONORS IN A TRANSFUSION DEPARTMENT OF CRETE
VALIDATION OF THE ABBOTT ARCHITECT SYPHILIS TP ASSAY FOR DONORS SPECIMENS
CONFIDENTIAL UNIT EXCLUSION PROCESS AND BLOOD SAFETY; THE IRANIAN BLOOD TRANSFUSION ORGANIZATION EXPERIENCE BETWEEN MARCH 2004 AND SEPTEMBER 2006
SEROEPIDEMIOLOGICAL DATA OF HIV INFECTION IN BLOOD DONORS IN TIRANA
EVALUATION OF THE ABBOTT PRISM HIV COMBINED ANTIBODY/ANTIGEN-ASSAY
THE OUTBREAK OF TRANSFUSION-TRANSMITTED HTLV INFECTION BY ONE BLOOD DONOR WITH HTLV IN KOREA
LONG-TERM ABNORMALITIES OF COMPLETE BLOOD COUNTS IN HUMAN T-LYMPHOTROPIC VIRUS TYPES I AND II (HTLV-I AND -II) INFECTION
ROLE OF INDONESIAN RED CROSS (IRC) IN REDUCING HIV TRANSMISSION THROUGH LINKED CONFIDENTIAL POLICY IN BLOOD TRANSFUSION SERVICE (BTS)
PREVALENCE OF HIV IN BLOOD DONORS IN NORTHERN INDIA USING FOURTH-GENERATION ENZYME-LINKED MMUNOSORBENT ASSAY
IDENTIFICATION OF HIV TRANSMISSION BY TRANSFUSION
PRISM HIV ANTIGEN-ANTIBODY COMBINATION ASSAY FOR BLOOD DONOR SCREENING
EVALUATION OF SENSITIVITY AND SPECIFICITY OF ABBOTT ARCHITECT HIV AG/AB COMBO ASSAY USING SEROCONVERSION PANELS, HIV TYPE/SUBTYPE SPECIMENS AND JAPANESE HOSPITALIZED SAMPLES
EVALUATION OF A HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN-ANTIBODY SCREENING ASSAY AFTER SOFTWARE UPGRADE
LYMPHOCYTE SUBSETS EVALUATION IN IRANIAN HIV NEGATIVE PATIENTS WITH IMMUNODEFICIENCY FEATURES REFFERED TO IRANIAN BLOOD TRANSFUSION RESEARCH CENTER
THE STRATEGY FOR ELIMINATING HBV. TRANSMISSION THROUGH BLOOD TRANSFUSION IN UNITED ARAB EMIRATES
PREVALENCE OF HEPATITIS G VIRUS AMONG IRNIAN BLOOD DONORS BY POLYMERASE CHAIN REACTION METHOD
THE PRESENCE OF THE HBSAG POSITIVE BLOOD DONORS DURING THE 2006 IN REPUBLIC OF MACEDONIA
HBV-DNA INVESTIGATION BY REAL-TIME PCR METHOD IN ISOLATED ANTI-HBC POSITIVE CASES AND MPOTANCE OF THESE CASES IN BLOOD BANKING
CELLULAR HCV-SPECIFIC IMMUNE RESPONSE AMONG RIBA-3 INDETERMINATE BLOOD DONORS
SERUM PREVALENCE OF MARKERS OF HEPATITIS B AND MANAGEMENT OF BLOOD DONORS IN A TRANSFUSION DEPARTMENT
HEPATITIS C VIRUS GENOTYPE PREVALENCE AMONG BLOOD DONORS FROM CENTRAL PORTUGAL
HUMAN HERPESVIRUS 8 (HHV-8) SEROPREVALENCE IN BLOOD DONORS FROM RIO DE JANEIRO, BRAZIL
EPIDEMIOLOGIC CHARACTERISTICS OF HBSAG (+) GREEK BLOOD DONORS IN A REGIONAL BLOOD TRANSFUSION CENTER (1999-2006)
SEROLOGIC MARKERS FOR HEPATITIS B IN BLOOD DONORS
IRON DEPLETION IN PATIENTS AFFECTED WITH CHRONIC HEPATITIS HCV-RELATED AND SECONDARY HEMOSIDEROSIS HAVE NOT BENEFICAL EFFECTS ON VIRAL REPLICATION
HBV MUTATIONS IN PRECORE/CORE REGION IN A GROUP OF CHRONIC HEPATITIS B PATIENTS
ALAT ACTIVITY TEST - A USEFUL TOOL FOR ELIMINATING VIRAL HEPATITIS CARRIERS FROM DONOR POPULATION?
BEHAVIOUR CHANGES AMONG HBS AND HCV POSITIVE DONORS TOWARD BLOOD DONATION, WHO DONATE AGAIN FOLLOWING NOTIFICATION
EVALUATION ABILITY OF DS-EIA-HBSAG-0.01 ASSAY TO REDUCE SEROCONVERSION WINDOW PERIOD
HIGH LEVELS OF ALANINE AMINOTRANSFERASE AS THE FIRST LABORATORIAL CAUSE OF REJECTED BLOOD DONATION IN THE COIMBRA UNIVERSITY HOSPITAL
CHARACTERISATION OF OCCULT HEPATITIS B IN BLOOD DONORS
MMUNODISREGULATION IN CHRONIC HEPATITIS C INFECTION
HCV AND HBV INFECTION MARKERS IN YOUNG VS. ADULT HAEMOPHILIA PATIENTS IN POLAND
HEPATITIS B VIRUS DETECTION IN POLISH BLOOD DONORS (1994-2004)
PREVALENCE OF HEPATITIS B, C AND HIV MARKERS IN THALASSEMIC AND HAEMOPHILIC PATIENTS IN ESFAHAN, IRAN, 2004
DETECTION OF HEPATITIS B VIRUS INFECTION IN A POPULATION OF HIV-1 INFECTED INDIVIDUALS IN RURAL ZIMBABWE
ANALYSIS OF THE CELLULAR IMMUNE RESPONSE IN NON VIREMIC BLOOD DONORS WITH ISOLATED ANTI-HCV REACTIVITY
HEV SCREENING FOR BLOOD DONORS
PERFORMANCE EVALUATION OF THE NEW ARCHITECT HCV AG/AB COMBO ASSAY FOR BLOOD SCREENING AND DIAGNOSTICS
IMPLICATION OF OCCULT HBV INFECTION IN TESTS FOR TRANSFUSION-TRANSMITTED VIRAL INFECTION
HEPATITS HCV
ANTIBODY PERFORMANCE REMAINS ESSENTIAL FOR EARLY DETECTION IN HCV ANTIGEN-ANTIBODY ASSAYS
TRANSFUSION TRANSMITTED HEPATITIS B - CASE REPORT
HEPATITIS B VIRAL INFECTION AMONG BLOOD DONORS -WHAT DO WE EXPECT
ACTUAL INCIDENCE OF HBV INFECTIONS IN REPEAT BLOOD DONORS IN NORTH-WEST ITALY
EVALUATION OF THE SPECIFICITY OF THE NEW HCV ANTIGEN/ANTIBODY COMBINATION ASSAY
PROTEOMIC STUDY OF HUMAN PLASMA
A FULLY AUTOMATED AND HIGHLY SENSITIVE MMUNO-ASSAY FOR HEPATITIS C VIRUS (HCV) CORE ANTIGEN
PREVALENCE OF INFECTIOUS MARKERS IN A HETEROGENEOUS BLOOD DONOR POPULATION AT HADASSAH HOSPITALS JERUSALEM, ISRAEL
WHY DO HEPATITIS C RATES CONTINUE TO DECREASE IN FIRST TIME DONORS?
BLOOD LETTING REDUCES HEPATIC INFLAMMATION IN PATIENTS AFFECTED WITH IRON OVERLOAD SECONDARY TO CHRONIC HEPATITIS HCV-RELATED
DEVELOPMENT OF A FLEXIBLE AND SENSITIVE IN-HOUSE REAL-TIME PCR ASSAY FOR THE QUANTIFICATION OF HBV DNA
ALANINE AMINOTRANSFERASE METHOD VALIDATION DESIGN ACCORDING TO TRACEABILITY CHAIN AND SIGMA LEVEL PERFORMANCE
OCCULT HEPATITIS B SURVEILLANCE IN BLOOD DONATIONS IN GREECE
CORRELATION BETWEEN THE PREVALENCE OF ANTI-HCV POSITIVE PATIENTS AND THE NUMBER OF RECEIVED BLOOD UNITS AND DURATION OF HEMODIALYSIS TREATMENT
HEPANOSTIKA HBSAG ULTRA AND CONFIRMATORY ASSAY
COST EFFECTIVENESS ANALYSIS FOR BLOOD DONOR SCREENING WITH SURROGATE PARAMETERS LIKE ALT AND NEOPTERIN
ANTI-HBC SEROCONVERSION IN VACCINATED AND NON-VACCINATED BLOOD DONORS SIGN OF RECENT HEPATITIS B INFECTION ?
ONE YEAR EXPERIENCE AFTER IMPLEMENTATION OF ANTI-HBC-TESTING INTO BLOOD DONOR SCREENING IN GERMANY
HBV-DNA DETECTION IN HBSAG NEGATIVE, ANTI-HBC POSITIVE BLOOD DONORS AND CORRELATION OF VIREMIA WITH OTHER MARKERS - ANTI-HBS, HBE AG, ANTI-HBE AND ALT
PREVALENCE OF SEN VIRUS INFECTION IN BLOOD DONORS IN IRAN
HDV INCIDENCE AMONG HBV-POSITIVE BLOOD-DONORS AND PATIENTS OF THE PIRAEUS GENERAL HOSPITAL ‘TZANEION’
THE PREVALENCE OF HBS AG-POSITIVE AND ANTI-HCV POSITIVE IN BLOOD DONORS
VIROLOGY PROFILE AND SERUM PROTECTION TO HEPATITIS B OF THE STAFF OF DISTRICT GENERAL HOSPITAL OF NIKEA. PIRAEUS
OCCULT HBV INFECTIONS IN THE ACUTE AND CHRONIC STAGE INTERDICTED BY TRANSCRIPTION MEDIATED AMPLIFICATION (TMA) TESTING OF SMALL DONOR POOLS
HBV CONFIRMATORY TESTING IN BLOOD DONORS
DETECTION OF HEPATITIS C CORE ANTIGEN AMONG BLOOD DONORS AND MULTITRANSFUSED PATIENTS IN SERBIA
THE INCIDENCE OF HEPATITIS B AND C INFECTIONS IN TRANSFUSION DEPENDANT THALASSAEMIA MAJOR PATIENTS IN PAKISTAN
TRACING OF ONE YEAR OF CHAGAS SCREENING AT THE CENTRO DE TRANSFUSION DE GALICIA (C.T.G.). CONCERNING A POSITIVE BLOOD DONOR
SEROPREVALENCE OF TRIPANOSOMA CRUZIANTIBODIES IN BLOOD DONORS IN MADRID AREA
CHAGAS SEROPREVALENCE IN BLOOD DONORS OF A NON ENDEMIC REGIONPERU 2003-2006
IMPLEMENTATION OF MALARIAE DISEASE SCREENING IN THE SPANISH BLOOD DONOR POPULATION. EVALUATION AND SELECTION OF SCREENING ASSAYS
MALARIA LOOKBACK PROGRAM USING MALARIA-PCR IN KOREA
EVALUATION OF A STRATEGY FOR TRYPANOSOMA CRUZI SCREENING AND ITS IMPACT ON BLOOD DONATION
STUDY OF THE PREVALENCE OF LEISHMANIASIS IN BLOOD DONORS FROM THE VALENCIAN COMMUNITY
PREVALENCE OF PALUDISM IN BLOOD DONORS IN THE VALENCIAN COMMUNITY
IMMUNOBLOT ASSAY USING RECOMBINANT ANTIGENS AS A SUPPLEMENTAL TEST TO CONFIRM ANTIBODIES TO TRYPANOSOMA CRUZI
PERFORMANCE CHARACTERISTICS OF THE ABBOTT PRISM TRYPANOSOMA CRUZI ANTIBODY SPECIFIC PROTOTYPE ASSAY*
AN UPDATE ON ROUTINE BACTERIAL MONITORING OF PLATELETS AT THE WELSH BLOOD SERVICE
CLINICAL AND SEROLOGICAL PROFILE OF BLOOD DONORS WITH FALSE-POSITIVE RPR TEST
BACTERIAL CONTAMINATION OF APHERESISPLATELETSTRA-CEDTO MAIN SOURCE
IMPROVEMENTS TO BLOOD CENTER MANAGEMENT BY THE IMPLEMENTATION OF PALL EBDS FOR ROUTINE BACTERIA SCREENING OF PLATELETS
SIX YEARS OF BACTERIAL SURVEILLANCE OF BLOOD PRODUCTS IN REGIONAL BLOOD TRANSFUSION CENTER IASI, ROMANIA (2001-2006)
USE OF THE PLATELET PGD TEST TO DETECT BACTERIA CONTAMINATION IN BUFFY COAT UNITS
ROUTINE MONITORING OF BACTERIAL CONTAMINATION IN BLOOD PRODUCTS AS A PART OF QUALITY MANAGEMENT SYSTEM
PROCESS CHANGES RESULTING IN IMPROVED BACTERIAL SCREENING
EVALUATION OF THE VERSATREK AUTOMATED MICROBIAL DETECTION SYSTEM FOR THE DETECTION OF BACTERIA IN PLATELET CONCENTRATES
DRAMATIC IMPROVEMENT OF DONOR ARM DISINFECTION EFFECTIVENESS USING THE CHLORAPREP DISINFECTION PROCEDURE
MICROBIOLOGICAL MONITORING AND QUALITY ASSURANCE AT THE BLOOD TRANSFUSION INSTITUTE OF SERBIA
COMPARISON OF A GEL TEST WITH OTHER CONFIRMATORY METHODS (FTA-ABS AND TPHA) FOR SYPHILIS IN BLOOD DONATIONS
THE RISK OF A BACTERIAL CONTAMINATION OF HEMOCOMPONENTS MUST FORCE TRANSFUSION CENTER TO IMPLEMENT PREVENTIVE MEASURES
COMPARISON STUDY OF TWO SCREENING TECHNIQUES FOR CHAGAS DISEASE IN BLOOD DONORS FROM THE VALENCIA REGIONAL COMMUNITY
NATIONAL HEALTH SERVICE BLOOD AND TRANSPLANT (NHSBT) EXPERIENCE DURING OPERATIONAL VALIDATION OF BACTERIAL MONITORING SYSTEMS IN TWO MAJOR BLOOD CENTRES IN ENGLAND
THREE YEAR REVIEW OF SYPHILIS SCREENING WITH ID-PAGIA SYPHILIS TEST
DETECTION OF BACTERIAL CONTAMINATION IN APHERESIS AND BUFFY COAT PLATELET PREPARATIONS IN CANADA
EVOLUTION OF SURVEILLANCE THE BACTERIAL CONTAMINATION OF PLATELETS TRANSFUSION IN A HOSPITAL
INTRODUCING OF STERILITY BLOOD AND BLOOD PRODUCTS CONTROL IN BLOOD TRANSFUSION INSTITUTE NIS
BACTERIAL CONTAMINATION OF TRANSFUSED PLATELET COMPONENTSEXPERIENCE OF ONE UNIVERSITY HOSPITAL
THE NEED FORNAT TESTING IN BLOOD TRANSFUSION SERVICES IN THE NEW MILLENNIUM
THE CLINICAL IMPORTANCE OF ANTI-HBC AS THE ONLY POSITIVE SEROLOGICAL MARKER OF HEPATITIS B VIRUS (HBV) AFTER THE IMPLEMENTATION OF NUCLEIC ACID TESTING IN INDIVIDUAL DONORS (ID NAT)
COMPARISON BETWEEN SEROLOGY AND NUCLEIC ACID TESTING RESULTS ON BLOOD UNITS
SIX MONTHS EXPERIENCE OF NAT IN THE BLOOD CENTER OF NORTHERNGREECE
ROCHE DIAGNOSTICS COBAS S 201 FRENCH EVALUATION
MULTI-CENTRE EVALUATION OF THE ROCHE COBAS S 201 SYSTEM
MINI-POOL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (NAT) COMBINED WITH SEROLOGY
AUTOMATED NAT BASED ON REAL-TIME PCR. ROUTINE SETTING AND EXTERNAL RUN CONTROL POLICY ADOPTED
EXPERIENCES IN NAT SCREENING PRIOR TO RELEASING CELLULAR COMPONENTS BY A BLOOD BANK OF ARGENTINA
COBAS S 201 SYSTEM
ANTI-HBC DETECTION IN BLOOD DONORS WITH DISCREPANT RESULTS IN ULTRIO ASSAY SCREENING
EXTERNAL QUALITY ASSESSMENT SCHEME FOR NUCLEIC ACID TESTING OF BLOOD DONATIONS AND PLASMA
EVALUATION OF THE NEW ARCHITECT CMV IGG ASSAY IN COMPARISON TO BIOTEST CMV IGG ASSAY
INTRODUCTION OF HBV NAT SCREENING ON BLOOD DONATION IN ITALY AND IDENTIFICATION OF HBV OCCULT INFECTION CASES
CONTRIBUTION OF MULTIPLE REAL-TIME PCR IN BLOOD DONORS
ADVANTAGES OF AN AUTOMATED SYSTEM FOR MULTIPLEXED REAL-TIME PCR SCREENING OF BLOOD DONATIONS
NUCLEIC ACID TESTING IMPLEMENTATION IN BLOOD SCREENING OF INTERMEDIATE ENDEMIC POPULATIONS OF SW GREECE
GREY ZONE UTILITY FOR MOLECULAR BIOLOGY TECHNIQUES. EXPERIENCE IN ROUTINE WORK
WHICH INDIVIDUAL DONATION (ID)-NAT TEST ALGORITHM HAS TO BE FOLLOWED FOR OPTIMAL SPECIFICITY AND MAXIMUM RECOGNITION OF BLOOD DONORS WITH OCCULT HBV INFECTION?
ANALYTICAL SENSITIVITY AND SPECIFICITY OF COBAS TAQSCREEN WEST NILE VIRUS TEST ON COBAS S 201 SYSTEM
SIMULTANEOUS DETECTION OF THREE VIRAL GENOMES IN BLOOD DONOR SCREENING WITH THE USE OF A SINGLE MOLECULAR ASSAY
EVALUATION AND ONE-YEAR EXPERIENCE USING HCV NAT BASED ON NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION FOR SCREENING BLOOD DONATIONS IN ARGENTINA
AUTOMATED NAT FOR BLOOD SCREENING OF 6 VIRUSES
CORRELATION OF ID-NAT RESULTS WITH CONFIRMATORY TESTING AMONG HCV SEROPOSITIVE GREEK BLOOD DONORS
IMPLEMENTATION OF PROCLEIX TIGRIS SYSTEM FOR NUCLEIC ACID TESTING OF THE BLOOD DONATIONS IN A TRANSFUSION CENTER
SENSITIVITY ANALYSIS OF THE PROCLEIX ULTRIO-TIGRIS SYSTEM FOR NUCLEIC ACID TESTING IN A SPANISH TRANSFUSION CENTER
EARLY EXPERIENCE WITH INDIVIDUAL HBV, HCV, HIV-1 NAT TESTING IN BLOOD DONATIONS IN NORTHWESTERN GREECE
HIGH PREVALENCE OF CYTOMEGALOVIRUS DNA IN PLASMA OF BLOOD DONORS IN CONNECTION WITH SEROCONVERSION
THE EFFECT OF PHOTOCHEMICAL TREATMENT (PCT) WITH AMOTOSALEN AND UVA LIGHT ON COAGULATION FUNCTION OF CONCURRENT PLASMA FROM PLATELET APHERESIS
THREE YEARS OF EXPERIENCE WITH THE INTERCEPTTM BLOOD SYSTEM FOR APHERESIS PLATELETS IN ROUTINE USE
STORAGE OF APHERESIS PLATELET CONCENTRATES TREATED WITH INTERCEPT SYSTEM
LEVELS OF COAGULATION FACTORS IN FRESH FROZEN PLASMA OBTAINED FROM WHOLE BLOOD DONATIONS AND PREPARED WITH TWO PHOTOCHEMICAL TREATMENT METHODS
IMPACT OF PHOTOCHEMICAL PATHOGEN INACTIVATION TREATMENT (INTERCEPT BLOOD SYSTEM FOR PLATELETS, IBSP) ON THE RESPONSE TO TRANSFUSION WITH 6-7 DAY OLD COMPONENTS
EVALUATION OF A NOVEL ILLUMINATION DEVICE FOR THE TREATMENT OF MB-PLASMA
IMPLEMENTATION OF PHOTOCHEMICAL PATHOGEN INACTIVATION (INTERCEPT BLOOD SYSTEM FOR PLATELETS) IN A REGIONAL BLOOD CENTER
EFFECT OF PHOTO INACTIVATION WITH METHYLENE BLUE ON SEROLOGICS TESTS RESULTS
ONE YEAR OF ROUTINE USE OF THE INTERCEPT BLOOD SYSTEM FOR PLATELET PATHOGEN INACTIVATION
OUR NINE YEARS EXPERIENCE IN PLASMA INACTIVATION
INACTIVATION OF SMALL NON-ENVELOPED VIRUSES IN PLASMA REDUCED PLATELET CONCENTRATES BY IRRADIATION WITH SHORT-WAVE ULTRAVIOLET LIGHT
CHARACTERIZATION OF ANTIBODIES TO RED CELLS PREPARED WITH S-303 PATHOGEN INACTIVATION TREATMENT
DEMONSTRATION OF AN S-303-INDUCED IMMUNE RESPONSE IN A NAVE RABBIT MODEL OF CHRONIC TRANSFUSION USING A SENSITIVE FLOW CYTOMETRY ASSAY
COAGULATION FUNCTION IN FRESH FROZEN PLASMA PREPARED WITH TWO PHOTOCHEMICAL TREATMENT METHODS
ADVERSE REACTIONS ASSOCIATED WITH METHYLENE BLUE INACTIVATED FRESH FROZEN PLASMA VS. STANDARD FFP
CHARACTERISTICS OF MACOPHARMA THERAFLEX MB-PLASMA
INACTIVATION OF CHIKUNGUNYA VIRUS IN PLATELETS AND PLASMA USING THE INTERCEPT BLOOD SYSTEM
ROBUSTNESS OF VIRAL INACTIVATION IN HIGH-DOSE INTERCEPT PLATELETS
PLATELET CONCENTRATES TREATED FOR PATHOGEN INACTIVATION USING THE INTERCEPTTM BLOOD SYSTEM
PLATELET COMPONENTS TREATED WITH PATHOGEN INACTIVATION USING THE INTERCEPTTM BLOOD SYSTEM
EVALUATION OF THE ARCHITECT CMV IGG ASSAY IN A SWISS BLOOD BANK- A PROSPECTIVE COMPARISON WITH THE AXSYM CMV IGG ASSAY
A COMPARISON OF TRANSFUSION OF STANDARD AND PATHOGEN INACTIVATED (INTERCEPTTM) PLATELETS WITH REGARDS TO CCI AND ACUTE TRANSFUSION REACTIONS IN HEMATOLOGICAL PATIENTS
PATHOGEN INACTIVATION OF DOUBLE DOSE APHERESIS PLATELETS USING THE INTERCEPT TM BLOOD SYSTEM
THERAFLEX UV PLATELETS
COMPARISON OF IMMUNOMODULATIVE SUBSTANCES AND SCD40L LEVELS IN LEUKOREDUCED, PHOTO-CHEMICALLY PATHOGEN INACTIVATED VS. UNTREATED PLATELET CONCENTRATES
BACKGROUND FOR IMPLEMENTATION OF SINGLE DOSE PLASMA PATHOGEN REDUCTION TECHNOLOGY IN RUSSIAN BLOOD SERVICE
DOES EXISTE AN ALTERNATIVE RECEPTOR TO P. VIVAX BEYOND DUFFY SYSTEM?
RBC ALLOIMMUNIZATION IN CHRONIC TRANSFUSION PATIENTS (THALASSEMICS)
THE FREQUENCIES OF ABO BLOOD GROUPS AND RHESUS FACTOR AMONG THE POPULATION OF ALBANIA
ABH ANTIGENS EXPRESSION AND SECRETOR STATUS OF PATIENTS WITH ORAL LESIONS
MOLECULAR GENETIC ANALYSIS OF THE FUT2 GENE
BLOOD GROUP AUTOMATION
PERFORMANCE OF AUTOMATED ANTIBODY SCREENING BY THE ERYTHROCYTE-MAGNETIZED TECHNOLOGY COMPARED TO GEL TESTS
IMPORTANCE OF ALLOGENEIC ADSORPTION TO DETERMINE THE INCIDENCE OF RED CELL ALLOANTIBODIES UNDERLYING WARM AUTOANTIBODIES
PROBLEMS IN MANAGEMENT OF TRANSFUSION IN PATIENTS WITH MULTILPLES ANTIBODIES AND WITH ANTIBODIES TO HIGH FREQUENCY ANTIGENS
WEAK RHD TYPES IN DENMARK, DO SEROLOGY AND GENETICS CORRELATE?
USE OF 0.8% CELL SUSPENSION FOR CROSSMATCHING BY IAT-IS THIS A MORE SENSITIVE METHOD COMPARED TO 3% CELL METHOD?
A CASE REPORT OF A PREGNANCY INVOLVING ANTI-INB AND FACTOR V LEIDEN
PERFORMANCE STUDY OF ANTIBODY SCREENING TEST USING THE ERYTHROCYTE MAGNETIZED TECHNOLOGY IN COMPARISON WITH GEL FILTRATION TESTS
THE FIRST ITALIAN REPORT OF AN ANTI- JOHN MILTON HAGEN (JMH) ANTIBODY, OF YET UNDEFINED CLINICAL SIGNIFICANCE, IN AN OLD WOMAN
A CLUE TO THE BASIS OF CIS-AB PHENOTYPE WITH HDN OCCURRENCE
IDENTIFICATION OF THE RARE AEL PHENOTYPE IN AN ITALIAN FAMILY
CHARACTERIZATION OF AN IMMUNE ANTI-P1 ANTIBODY IN A SUBJECT WITH MONOBLASTIC ACUTE LEUKAEMIA
CELLBIND SCREEN MICRO COLUMN AFFINITY TEST
ANTI-LAN IN A WOMAN WITH THE RARE LAN NEGATIVE PHENOTYPE
AUTOIMMUNE HAEMOLYTIC ANAEMIA IN THE CHILD WITH OVARIAN DERMATOID CYST
IMMUNOHEMATOLOGICAL EVALUATION OF AINT EXPRESSION BY OPTICAL METHODS
ANTIGEN SPECIFIC IMMUNOADSORPTION AND IMMUNOSUPPRESSIVE THERAPY TO UNDERGO ABO INCOMPATIBLE KIDNEY TRANSPLANTATION
MICROPLATE RH (D) NEGATIVE BLOOD GROUP
ANALYSIS OF A SURFACE OF ENZYME TREATED RED BLOOD CELLS
IDENTIFICATION OF ALLOANTIBODIES IN MULTIPLY TRANSFUSED PATIENT ANDPREVENTION OF ACUTE HEMOLYTIC TRANSFUSION REACTION
ANTI-U-LIKE AS AN ALLOANTIBODY IN U- AND U+VAR INDIVIDUALS
AN AUTOANTIBODY TO A HIGH-INCIDENCE ANTIGEN OF GLYCOPHORIN B, SELECTIVELY DESTROYED BY CHYMOTRYPSIN AND PRONASE
PRELIMINARY RESULTS OF BLOOD GROUP TYPING IN VOLUNTARY BLOOD DONORS USING MICROPLATE TECHNIQUE
SCREENING OF IRREGULAR ANTIBODIES IN BLOOD DONORS
REVIEW OF ALLOIMUNIZATION IN THE HOSPITAL PATIENTS -COPMARISON OF ANTIBODY DETECTION BETWEEN TUBE AND GEL METHODS (1996-2006)
SEROLOGICAL DETECTION OF DEL ANTIGEN USING A MONO-LAYER COAGGLUTINATION TECHNIQUE ON MICROPLATES
INCIDENCE OF DELAYED HEMOLYTIC AND SEROLOGIC TRANSFUSION REACTIONS
ANTI-D MMUNIZATIONIN A D-POSITIVE MOTHER
CLINICAL IMPORTANTANCE OF RED CELL ALLOANTIBODIES DETECTED IN 10 YEARS PERIOD IN GENERAL HOSPITAL IZOLA
ABO GROUPING - SEROLOGICAL DETECTION OF A MIXED FIELD REACTION WITHIN THE UK, PORTUGAL AND DENMARK
ASSESSMENT OF SUBCASSES IGG1 AND IGG3 AND THEIR RELANTIONSHIP WITH RISK OF HEMOLYSIS IN IGG CLASS DIRECT ANTIGLOBLULINE TEST POSITIVE PATIENTS
PREVALENCE AND SPECIFICITY OF IRREGULAR ERYTHROCYTE ANTIBODIES IN PREGNANT WOMEN IN TWO INSTITUTIONS OF ROSARIO ARGENTINA
COMPARISON OF GEL TEST AND TUBE TEST TECHNIQUE FOR ISOAGGLUTININSTITRATION
EVALUATION OF A NEW METHOD ERYTHROCYTES MAGNETISED TECHNOLOGY FOR BLOOD GROUPING, PHENOTYPNG & ANTIBODY SCREENING
A SEVERE CASE OF HYDROPS OF IMMUNE ETHIOLOGY IN A NEONATE
ERYTHROCYTE ALOANTIBODIES AND DELAYED HEMOLYTIC TRANSFUSION REACTION
COMPARISON OF MICROTUBE COLUMN AGGLUTINATION FOR BLOOD GROUP TYPING AND ANTIBODY SCREENING
ERYTHROCYTE ALLOANTIBODIES PRODUCED AFTER BONE MARROW TRANSPLANTATION
BLOOD SERVICE IN RUSSIAN FEDERATION IN 2005
ERYTHROCYTE AGING
COMBINED PLASMA EXCHANGE AND INTRAVENOUS IMMUNOGLOBULIN AS NON-INVASIVE TREATMENTS IN TWO CASES OF SEVERE RHD ALLOIMMUNIZATION DURING PREGNANCY
GEOGRAPHICAL DISTRIBUTION OF PHENOTYPE RH IN EXTREMADURA
ASSOCIATION OF BLOOD GROUP PHENOTYPES [ABO, RH (D) AND LEWIS] AND CORONARY RISK FACTORS WITH ATHEROSCLEROTIC CORONARY ARTERY DISEASE IN NORTH INDIA
ANTIBODY FRONT AN ERYTHROCYTE ANTIGEN OF HIGH FREQUENCY (CELLANO) IN HOSPITALARY CENTER OF REFERENCE
EVALUATION OF METHODOLOGY FOR MEASUREMENT OF IGM ANTI-A AND ANTI-B AND NORMAL RANGES IN A POPULATION OF DANISH BLOOD DONORS
THE FIRST EXAMPLE OF DETECTED ANTI LAN ANTIBODY IN SERBIA
WHY ANTI-P IS NOT ALWAYS DETECTED IN ACUTE PAROXYSMAL COLD HEMOGLOBINURIA (PCH) BY INDIRECT ANTIGLOBULIN TEST (IAT)?
ANTI-K (KEL 2) ALLOANTIBODIES IN PATIENT REQUIRING URGENT SURGERY
RED CELL ALLOIMMUNIZATION IN TRANSFUSED PATIENT POPULATION - A STUDY FROM A TERTIARY CARE HOSPITAL IN NORTH INDIA
HAEMOLYTIC DISEASE OF NEWBORN CAUSED BY RH ANTIBODIES (ANTI-C & ANTI-E) IN RH (D) POSITIVE MOTHERS
FREQUENCY OF RBC ANTIBODIES IN PREGNANT WOMEN
ABO AND RH (D) PHENOTYPE FREQUENCIES OF BLOOD DONORS IN GREECE
DIFFICULTY TO IDENTIFY AN ANTI-CE(F) IN A POLYTRANSFUSED PATIENT CANDIDATE FOR LIVER TRANSPLANTATION
TEN YEARS EXPERIENCE
ABH GROUP SYSTEM AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAIT) G.FRATELLANZA IMMUNOHAEMATOLOGY- TIN AOP FEDERICO II NAPOLI
THE USEFULLNESS OF AUTOLOGOUS CRYOPRESERVED PLATELETS IN A PATIENT WITH REFRACTORINESS TO TRANSFUSION PLATELETS (CASE REPORT)
COMPARISON OF THE USE OF SERUM AND PLASMA SAMPLES FOR THE DETECTION OF HLA CLASS I AND CLASS II ANTIBODIES
PLATELET SPECIFIC ANTIBODIES TESTING
HPA-1,-5 AND HPA-15 FREQUENCIES IN A PORTUGUESE DONOR POPULATION
PLATELET ALLOIMMUNIZATION DUE TO PLATELET-REACTIVE ANTIBODIES IN PATIENTS SHOWING PLATELET REFRACTORINESS FOLLOWING MULTIPLE PLATELET TRANSFUSIONS
HUMAN PLATELET ANTIGEN GENE FREQUENCY IN IRANIAN BLOOD DONORS
ALLOIMMUNIZATION CAUSED BY SPECIFIC PLATELET ANTIBODIES IN PREGNANT WOMEN WITH THROMBOCYTOPENIA
SUCCESSFUL FINDING OF APHERESIS DONORS FOR HIGHLY SENSITISED PLATELET REFRACTORY PATIENTS BY SINGLE HLA-ANTIGEN COATED BEADS
SELECTING THE MOST OPTIMAL METHOD FOR THE DETECTION OF HLA CLASS I ANTIBODIES
HLA AND IN LEUKEMIA PATIENTS
NEW NON-CLASSICAL HLA CLASS I ALLELES
DETERMINATION OF ABO GLYCOSYLTRANSFERASES GENOTYPES BY USE OF PCR (POLYMERASE CHAIN REACTION) IN HUMAN SPERM
NON-INVASIVE FETAL RHD DETERMINATION IN GESTATION WEEK 15 AND 25
THE MOLECULAR STUDY OF THE RH SYSTEM PROVIDES SOME INSIGHT INTO THE ETHNIC ORIGINS OF THE ARGENTINIAN POPULATION
DISCREPANT PHENOTYPING AND GENOTYPING RESULTS AT THE RHCE GENE IN CASE OF AN APPARENT MOTHER/CHILD EXCLUSION
WEAK KEL 2 EXPRESSION IN BLOOD DONORS WITH NEW POLYMORPHISMS IN KEL GENE EXONS 13 AND 16
PRENATAL RHD GENOTYPING USING MATERNAL PLASMA
RHD NULL ALLELES IN THE SPANISH POPULATION
POLYMORPHISM OF THE DRB1 ALLELES IN ARGENTINIANS CHAGASIC PATIENTS WITH AND WITHOUT CARDIOMYOPATHY
RECENT DEVELOPMENTS IN NON-INVASIVE FETAL RHD GENOTYPING
ERRORS IN ABO TYPING OF BLOOD USING SEROLOGICAL METHODS. THE CLINICAL USE OF GENOMIC BLOOD GROUPING
HAEMOLYTIC ANEMIA AFTER FLUDARABINE THERAPY IN A PATIENT WITH CLL
ANEMIA DUE TO ANTI-KPA ANTIBODY IN A NEWBORN
THE FETOMATERNAL INCOMPABILITY AND THE GENDER OF THE NEWBORN
HYPERHEMOLYSIS SYNDROME IN A PATIENT WITH DELTA - BETA THALASSEMIA
COMBINED MEGALOBLASTIC AND MMUNOHAEMOLYTIC ANAEMIA-CASE REPORT
THE CLINICAL SIGNIFICANCE OF ANTI-JR (A)
AUTO ANTI-D IN A MAJOR BETA-THALASSEMIC PATIENT
A BIOCHEMICAL COMPARISON OF A PHARMACEUTICALLY LICENSED S/D TREATED PLASMA WITH A UNIVERSALLY APPLICABLE DEVELOPMENT PRODUCT AND FFP UNITS SUBJECTED TO METHYLENE-BLUE DYE AND WHITE-LIGHT TREATMENT
THROMBIN GENERATION CAPACITY IS IMPAIRED IN MB TREATED PLASMA UNITS COMPARED TO FFP, A PHARMACEUTICALLY LICENSED S/D TREATED PLASMA PRODUCT AND A UNIVERSALLY APPLICABLE S/D PLASMA UNDER DEVELOPMENT.
ALLO IMMUNIZATION IN MULTIPLY TRANSFUSED SURGICAL PATIENTS
THE USE OF RECOMBINANT FACTOR VII IN POSTPARTUM HEMORRHAGE
SPECIFICITY OF PEDIATRIC BLOOD TRANSFUSION
HAEMOLYSIS CONTROL IN ARED CELL CONCENTRATE OBTAINED FROM A DONOR WITH HEREDITARY SPHEROCYTOSIS
POST TRANSFUSIONAL COMPLICATIONS IN MULTIPLE TRANSFUSED THALASSEMIC PATIENTS
FETOMATTERNAL IMMUNIZATION-CASE REPORT
INCIDENCE OF FEBRILE NON-HAEMOLYTIC TRANSFUSION REACTIONS IN NEWBORNS AND IN CHILDREN AFTER PLASMA REDUCTION AND LEUKODEPLETION OF PLATELET CONCENTRATES
EVALUATION OF FRESH FROZEN PLASMA TRANSFUSION PRACTICES IN KOREAN HOSPITAL
ABO SYSTEM HEMOLYSINS IN CHILDREN WITH ASCARIASIS
PYRUVATE-KINASE DEFICIENCY
STORAGE COMPARISON OF CORD BLOOD AND DONATED BLOOD
TREATMENT OF HEMOLYTIC DISEASE IN THE NEWBORN WITH BLOOD COMPONENTS
USE OF RECOMBINANT FACTOR VII IN A NEWBORN WITH SEVERE BLEEDING
THE USE OF RED CELLS IN THE TREATMENT OF ANEMIA IN HAEMATOLOGICAL PATIENTS-OUR EXPERIENCES LJILINCIC BMIHIC SSTOJKOVIC MBOZOVIC VDJUROVIC MRADOJKOVIC SRISTIC; KBC DR DMISOVIC BELGRADE SERBIA
A REVIEW OF THE CONSUMPTION OF BLOOD AND BLOOD PRODUCTS AT THE DEPARTMENT OF GYNEACOLOGY AND OBSTETRICS AT THE GENERAL HOSPITAL IN TETOVO IN THE PERIOD BETWEEN JANUARY-DECEMBER 2006
OUR EXPERIENCES IN THE USE OF BLOOD COMPONENTS IN CARDIAC SURGERY IN THE PERIOD1998-2006
OUR EXPERIENCE IN THE USE OF FRESH FROZEN PLASMA IN THE INTERNAL MEDICINE PATIENTS
EFFECTS OF RECOMBINANT ERYTHROPOIETIN IN THERAPY HAEMODIALYSIS PATIENTS WITH CONSEQUENCE OF RATIONAL USE OF BLOOD
UTILIZATION OF BLOOD AND BLOOD PRODUCTS IN THE PUBLIC HEALTH INSTITUTION ‘GENERAL HOSPITAL’ - STRUMICA
THE USE AND ABUSE OF FRESH FROZEN PLASMA OUR EXPERIANCE IN CARDIAC SURGERY PATIENTS
PLASMA PRODUCTS TRANSFUSION STRATEGIES IN PATIENTS UNDERGOING CYTOREDUCTIVE SURGERY (CRS) AND INTRA-PERITONEAL HYPERTERMIC PERFUSION (IPHP)
A TYPE OF PATIENTS CLINICIANS ARE SENDING TO TRANSFUSION INSTITUTE FOR ANEMIA CORRECTION (A 5 YEARS FOLLOW UP)
EU OPTIMAL BLOOD USE PROJECT
THE EFFECT OF UNIVERSAL LEUKOREDUCTION ON PACKED RED CELL TRANSFUSION
APPLICATION OF TRANSFUSION MEDICINE PRINCIPLES IN SURGICAL PATIENTS AT THE CLINICAL HOSPITAL CENTER ZVEZDARA, BELGRADE, SERBIA
DETERMINING THE PREDICTING FACTOR OF BLOOD TRANSFUSION DURING CORONARY ARTERY BYPASS SURGERY DEPENDING ON PATIENT STATUS AND PRE-OP FACTORS IN NAMAZI HOSPITAL IN SHIRAZ IN 2004
IMPORTANCE OF IMPLEMENTING A MSBOS IN A HOSPITAL
POLYCYTHEMIA VERA-THERAPEUTIC APPROACH
AUDIT OF FRESH-FROZEN PLASMA USE TO IMPROVE TRANSFUSION PRACTICES
CLINICAL USE OF BLOOD IN ORTHOPEDY
CLINICAL USE OF BLOOD IN THE PERIOD OF SEVEN YEARS
LOGISTICS FOR CMV DETECTION IN BLOOD DONATIONS AND COMPONENT PREPARATION
INFLUENCE OF BLOOD TRANSFUSION AND PERIOPERATIVE ANEMIA ON LONG TERM SURVIVAL OF PATIENTS OPERATED FOR NON SMALL CELL LUNG CANCER
QUALITY OF THE TRAINING RECEIVED IN A TRANSFUSION CENTRE
EUTHANASIA ISSUE
PROVISION OF THE LUMINEX SINGLE ANTIGEN FOR THE SELECTION OF PLATELETS TO TRANSFUSE TO HYPERIMMUNE PATIENTS IN THE HLA SYSTEM
DEVELOPMENT OF A PLAN OPTIMIZATION OF USE RED CELLS RH D NEGATIVES
RADIOSYNOVECTOMY WITH P32 IN PATIENTS WITH HEMOPHILIC ARTHROPATHY
HOW WE CAN IMPROVE THE HOSPITAL BLOOD BANKS?
INFLAMMATORY MEDIATORS AND QUALITY OF INTRA-OPERATIVE SALVAGED BLOOD DURING HIP ARTHROPLASTY. A CLINICAL STUDY OF HEPARIN-COATED AND NON-HEPARIN-COATED AUTOTRANSFUSION SYSTEMS
AUTOLOGOUS BLOOD DONATION IN SPAIN (19942004)
HAEMOGLOBIN AND FERRITIN ARE RISK FACTORS FOR ALLO-GENIC TRANSFUSION IN PATIENTS ADMITTED TO A PREOPERATIVE AUTOLOGOUS BLOOD DONATION (PABD) PROGRAM
IS THE EXPOSURE TO EPOETIN ALFA A COST-EFFECTIVE THERAPY IN ORTHOPAEDIC KNEE REPLACEMENT?
CHOMATOGRAPHIC ISOLATION OF AT III FROM HUMAN PLASMA
RISK FACTORS FOR HOMOLOGOUS TRANSFUSION IN AUTOLOGOUS BLOOD DONORS UNDERGOING PRIMARY TOTAL HIP ARTHROPLASTY
CELL SALVAGE REDUCES THE NEED FOR ALLOGENEIC BLOOD IN REVISION HIP SURGERY
THE SEVILLE CONSENSUS DOCUMENT ON ALTERNATIVES TO ALLOGENEIC BLOOD TRANSFUSIONS
THE USAGE OF TRANSFUSION ALTERNATIVES AS A SUBSTITUTION OF ALLOGENIC TRANSFUSION ON THE OPERATED PATIENTS
HOW WOULD WE SPEND IF WE TREATED CANCER RELATED ANAEMIA WITH EPO?
IMPLEMENTATION OF THE PROGRAM OF AUTOLOGOUS DONATION
THE USE OF FIBRIN GLUE AND EPIDERMAL GROWTH FACTOR (EGF) ON THE COLON ANASTOMOSIS
EVALUATION OF TWO REAL-TIME TAQMAN PCR ASSAYS FOR DETECTION OF GENETIC MARKERS OF THROMBOPHILIA
EVALUATION OF PLASMA TOTAL HOMOCYSTEINE CONCENTRATION IN PATIENTS WITH THROMBOSIS
HEMOPHILIA INFORMATION SYSTEM OF MACEDONIA - HISM
PREPARATION OF FIBRIN SEALANT USING METHYLENE BLUE TREATED PLASMA USING THE CRYOSEAL FS -SYSTEM
LOW MOLECULAR WEIGHT HEPARIN PREVENTION IN ORTHOPEDIC PATIENTS WITH HIGH RISK
EVALUATION OF METABOLIC PARAMETERS IN PLATELET CONCENTRATES STORED FOR 5 DAYS
MANIPULATION OF FIBRINOLYTIC SYSTEM AND ANGIOGEN-ESIS BY ANTIPLASMINOGEN MONOCLONAL ANTIBODIES
RELEASE OF POTENTIAL MMUNOMODULATORY FACTORS DURING PLATELET STORAGE
DICUMAROL AND CHANGE IN LIVER METABOLISM
ANALYSIS OF THE EFFECTIVE AGENTS IN DEVELOPMENT OF FACTOR INHIBITOR IN HEMOPHILIC PATIENTS EVALUATION OF 445 PATIENTS IN CENTRAL PART OF IRAN
INHERITED COAGULATION DISORDERS IN CENTRAL PART OF IRAN
ADENOCARCINOMA, PREGNANCY AND BIRTH OF HEALTHY BABY
THE EFFECT OF PRESTORAGE FILTRATION ON PLATELET ACTIVATION IN PLATELET CONCENTRATES
PLATELET GEL IN POST-SURGICAL INFECTED WOUND. CASE-REPORT.
ADVERSE EFFECT OF ASPIRIN IN PREGNANT WOMAN
PROTECTION OF PLASMA FIBRINOGEN WITH HISTIDINE DURING RADIATION STERILIZATION
HAEMOVIGILANCE FOR HAEMATOLOGICAL PATIENTS
HAEMOVIGILANCE FOCUSED ON BLOOD DONORS REACTIONS
THE CLINICAL SEGMENT OF THE TRANSFUSION CHAIN
BLOOD GROUP CONFIRMATION AT BEDSIDE
POST-NOTIFICATION DATA AMONG HIV (+)DONORS
REPORTED CASES OF IBCT TO THE NORWEGIAN HEMOVIGILANCE SYSTEM, TROLL. WHAT DID GO WRONG
DONOR HAEMOVIGILANCE
POST TRANSFUSION REACTION
FUNCTIONING OF THE CLINICAL TRANSFUSION MEDICINE PRACTICE SURVEILLANCE IN THE REPUBLIC OF SERBIA
EVALUATION OF A NEW TRANSFUSION IDENTIFICATION SECURITY SYSTEM WITH FINGERPRINT SENSOR AND TRANSFUSION RESULT TRANSMISSION
POSTTRANSFUSION REACTIONS REPORTED TO THE BLOOD TRANSFUSION INSTITUTE-A FIVE YEARS FOLLOW UP
HEMOVIGILANCE - FOUR YEARS ANALYSIS OF TRANSFUSION INCIDENTS IN THE HRADEC KRALOVE UNIVERSITY HOSPITAL
DONOR COMPLICATIONS AND REACTIONS TO WHOLE BLOOD DONATION
IMPACT OF NEW DEFINITIONS ON TRENDS IN THE REPORTING OF ADVERSE TRANSFUSION REACTIONS (ATRS) IN THE QUEBEC HEMOVIGILANCE SYSTEM (QHS)
EVALUATION OF THE TRACEABILITY OF BLOOD PRODUCTS AND TRANSFUSION SAFETY IN SPAIN
HAEMOVIGILANCE AND BLOOD DONATION
INCIDENCE RATE OF ACUTE BLOOD TRANSFUSION REACTIONS IN IRANIAN PATIENTS
PROGRESS OF HAEMOVIGILANCE PROGRAMME IN BRNO FACULTY HOSPITAL
USING QUALITY REPORTING SYSTEMS TO ESTABLISH A NATIONAL HAEMOVIGILANCE PROGRAM IN AUSTRALIA
REVIEW OF THE INCIDENCE OF TRANSFUSION-RELATED ACUTE LUNG INJURY (TRALI) IN NAVARRA HOSPITAL
HEMOVIGILANCE CONTRIBUTION TO THE IMPROVEMENT OF TRANSFUSION PROCESS AND PRACTICE
IMPLEMENTATIONS OF ISBT 128 BLOOD LABELING IN BLOOD TRANSFUSION INSTITUTE NIS - SOUTH SERBIA
IMPROVEMENT IN THE EFFICIENCY OF THE BLOOD COMPONENTS LABORATORY WITH THE IMPLEMENTATION OF THE LEAN MANUFACTURING PRINCIPLES
MAKING A BLOOD CENTER WAREHOUSE EU COMPLIANT
A NEW SYSTEM FOR TEMPERATURE STABLE TRANSPORT OF BLOOD PRODUCTS
QUALITY ASSURANCE SYSTEM - EXPERIENCES OF BLOOD COMPONENTS QUALITY CONTROL IN POLISH REGIONAL BLOOD CENTERS IN THE PERIOD 2000-2006
USE AND VALIDATION OF POOLED HIV, HBSAG AND HCVPOSITIVE SERA FOR QUALITY CONTROL IN SCREENING FOR TRANSFUSION TRANSMISSIBLE INFECTION'S IN A BLOOD TRANSFUSION SERVICES
MONITORING AND IMPROVEMENT OF PRE-TRANSFUSION RECORDING ACTIVITIES
IMPLEMENTATION OF ISBT 128 BLOOD LABELING IN TURKISH RED CRESCENT BLOOD SERVICES ORGANIZATION
THE VALIDATION PROCES OF A NEW AUTOMATED WHOLE BLOOD PROCESSING SYSTEM (ATREUS) DURING ONE WEEK ROUTINE PRODUCTION
AUSTRALIAN NATIONAL BLOOD AUTHORITY'S INTERNATIONAL FRESH BLOOD BENCHMARKING PROJECT
THE QUEST FOR QUALITY
LEARN HOW ERROR/CAPA (CORRECTIVE AND PREVENTATIVE ACTION) MANAGEMENT CUTS RISK IN BLOOD BANKING
CREATING A SUCCESSFUL QUALITY PROGRAM FOR BLOOD AND TISSUE
MOBILIZATION OF HIGH LEVELS OF PERIPHERAL BLOOD PROGENITOR CELLS IN PATIENTS AFFECTED BY MULTIPLE MYELOMA AGING MORE THAN 65 YEARS
AUTOLOGOUS PERIPHERAL BLOOD STEM CELL APHERESISIN MULTIPLE MYELOMA PATIENTS
OCCURRENCE OF SIDE EFFECTS DURING AUTOLOGOUS PERIPHERAL BLOOD HEMATOPOIETIC PROGENITOR CELL INFUSION IS ASSOCIATED WITH COMPOSITION OF GRAFT
MICROBIAL CONTAMINATION OF HEMATOPOIETIC PROGENITOR CELL GRAFTS
MOBILIZATION OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS BY CHEMOTHERAPY AND SINGLE DOSE PEGFILGRASTIM IN PATIENT WITH HAEMATOLOGICAL MALIGNANCIES
PBPC COLLECTIONS AND FOLLOW UP IN DONORS AFTER MOBILIZATION AND COLLECTION
CORRELATION BETWEEN CD34 + CELL DOSE INFUSED IN AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION AND HEMATOPOIETIC RECONSTITUTION AND BLOOD COMPONENTS REQUIREMENTS
RETROSPECTIVE STUDY OF MOBILIZATION RESULTS FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN HIV RELATED LYMPHOMA
A NOVEL SOURCE OF HUMAN HAEMOTAPOIETIC STEM AND PRIMARY CELLS
LARGE-VOLUME LEUCAPHERESIS IN PEDIATRIC PATIENTS
CORD BLOOD NACIONAL PROGRAM
MEDICAL EDUCATION MODEL FOR UMBILICAL CORD BLOOD COLLECTION AND STORAGE
UMBILICAL CORD BLOOD CD133 POS CELLS CONTAIN PRIMITIVE CELLS ABLE TO PRODUCE DIFFERENT CATEGORIES OF COLONY FORMING UNIT MEGAKARYOCYTES IN VITRO IN COMPARISON WITH CD133 NEGCELLS
THE PROLIFERATION OF NATURAL KILLER T CELLS IN UMBILICAL CORD BLOOD OR PERIPERAL BLOOD, THE DIFFERENT PHENOTYPE BETWEEN THEM AND THEIR ANTI-TUMOR IMMUNITY
INFLUENCE OF STRESS FACTORS DURING DELIVERY ON CORD BLOOD QUALITY
OUTCOMES OF A PROGRAM TO EVALUATE MATERNAL SEROLOGY AND BABIES AFTER UMBILICAL CORD BLOOD DONATIONS
ABO MISMATCHED BONE MARROW PROCESSING FOR TRANSPLANTATION WITH THE AUTOMATED, CLOSE-SYSTEM DEVICE SEPAX
CHARACTERIZATION OF FRESH AND CULTURED HUMAN ADIPOSE TISSUE-DERIVED CELLS
PREPARATION AND ISOLATION OF MONOCYTES FROM WHOLE BLOOD DERIVED BUFFY COAT BY CONTINUOUS COUNTER-FLOW ELUTRIATION
CRITICAL ROLES OF THE TGF-B IN CHONDROGENESIS ANALYZED BY FLUORESCENCE CORRELATION SPECTROSCOPY
BEREAVEMENT SUPPORT PROGRAM UPDATE FOR DONOR FAMILIES
ANALYSIS OF IMPACT IN TISSUE DONORS REJECTION AFTER IMPLEMENTATION OF ANTI-HBC TEST IN A TISSUE BANK IN SPAIN
THE IMPORTANCE OF A STABLE RED CELL INVENTORY IN REDUCING WASTAGE
INTEGRATED BLOOD INVENTORY MANAGEMENT PORTO REGIONAL BLOOD CENTRE
IMPROVED PLATELETS INVENTORY MANAGEMENT PORTO REGIONAL BLOOD CENTRE
SELECTION OF PLASMA COMPONENTS FOR TRANSFUSION IN A GENDER PERSPECTIVE. CONSEQUENCES FOR THE LOGISTICS AND QUALITY CRITERIA
DONOR AND BLOOD COMPONENT STORAGE INTEGRATION THE EXPERIENCE OF CASTILLA-LA MANCHA SPAIN
ADEQUATE PHENOCOMPATIBLE RED CELLS AND HLA FOR THALASSAEMIC PATIENTS
SEASONAL VARIABILITY OF BLOOD INVENTORY IN POLAND -A NATIONAL SURVEY
REDUCTION OF PLATELET CONCENTRATE UNUTILIZATION DUE TO AGGREGRATES AND EXPIRY DATE BY IMPLEMENTATION OF BUFFY COAT PROCEDURE
IMPACT OF NANOTECHNOLOGIES ON BLOOD SCREENING
PERFORMANCE EVALUATION OF THE NEW ARCHITECT RHTLV-I/II ASSAY FOR BLOOD SCREENING AND DIAGNOSIS
PRE-ANALYTIC AND POST- ANALYTIC AUTOMATION IN A BLOOD CENTRE
PLATELET AND LEUKOCYTE DERIVED GROWTH FACTORS FOR THE TREATMENT OF CHRONIC TENDINOPATHY IN ATHLETES
MEASUREMENT OF PLATELET CONCENTRATE (PC) FUNCTION USING THE DIAMED IMPACT R PLATELET ANALYSER
PROTEIN MISFOLDING CYCLIC AMPLIFICATION USING HUMAN TISSUES
PREIMPLANTATION HLA COMPATIBILITY EVALUATION BY STR TYPING AND FANCE GENE MUTATIONS DETECTION
REAL-TIME PCR WITH HYBRIDIZATION PROBES AS A TOOL FOR HLA POLYMORPHISM DETECTION. COMPARISON BETWEEN APPROACHES AND FINAL CONCLUSIONS
EVALUATION OF LINEAR AND NONLINEAR DYNAMIC VISCOELASTIC BEHAVIOUR OF STORED RED BLOOD CELLS
OPERATIONAL EVALUATION OF THE PRDT/MACOPHARMA P-CAPT PRION REDUCTION FILTER
EFFECTS OF LEUKOCYTE-DEPLETED RBC TRANSFUSIONS ON CYTOKINE PROFILES AND COMPLICATIONS AFTER CARDIAC SURGERY
LARGE SCALE USE OF PLATELET ADDITIVE SOLUTIONS (PAS) REDUCES ALLERGIC TYPE TRANSFUSION ADVERSE EVENTS
PRE-OPERATIVE RISK FACTORS FOR A RED BLOOD CELL TRANSFUSION IN ELECTIVE ORTHOPAEDIC SURGERY
UTILIZING POST TRANSFUSION (TRANSFUSION ASSOCIATED) GRAFT-VERSUS-HOSTDISEASEASATOOLFORDISCOURAGING DIRECTED DONATION AND FRESH BLOOD USAGE
POSTGRADUATE EDUCATIONAL ACTIVITIES IN THE BLOOD TRANSFUSION INSTITUTE OF SERBIA
A KAP STUDY EVALUATING PHYSICIANS AND NURSES IN UNIVERSITY HOSPITALS WITH HOSPITAL TRANSFUSION COMMITTEES (HTC) COMPARED TO THOSE WITHOUT HTC
PROTOCOL TO MAKE EXTERNAL ACTIVITIES FORMATIVAS OF SANGUINEOUS TRANSFUSION OF HUELVA IN CENTER
TRANSFUSION MEDICINE
APPLICATION OF MATHEMATICAL CALCULATIONS AND MATHEMATICAL CHARTS IN THE PRACTICE OF EVIDENCE BASED TRANSFUSION MEDICINE
ASSESSMENT OF WILMS TUMOR GENE (WT1) IN ACUTE MYELOID LEUKEMIA PATIENTS AS A NEW MARKER TO DETECT MINIMAL RESIDUAL DISEASE(MRD)
MMUNOTHERAPY IN RECURRENT SPONTANEOUS ABORTION
SEVERE HAEMOLYSIS RESULTING FROM RH(D) INCOMPATIBILITY IN A CASE OF ABO-IDENTICAL LUNG TRANSPLANT
DROP BY DROP
NURSE CARE RECORDING IN BLOOD DONORS
INCOHENCES OR ATYPICAL VALUES IN THE NATIONAL BASIS OF HEMOVIGILANCE
AUTOLOGOUS PRE-DEPOSITION OF BLOOD FOR NO-ACUTE SURGICAL CASES (103 MONTHS EXPERIENCE)